| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Common Stock | 7.67K | $563K | $73.36 | Oct 1, 2025 | Direct |
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Option to Purchase Common Stock | 9.03K | Oct 3, 2025 | Direct | ||
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF OPERATING OFFICER | Restricted Stock Units | 3.63K | Oct 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Oct 3, 2025 | 2 | $0 | 4 | Oct 6, 2025 | SVP, CHIEF OPERATING OFFICER |
| HALO | HALOZYME THERAPEUTICS, INC. | Oct 1, 2025 | 0 | $0 | 3 | Oct 6, 2025 | SVP, CHIEF OPERATING OFFICER |